NICE decision for use of Translarna - a criminal act

The decision this week from NICE in the UK to deny boys with Duchenne Muscular Dystrophy the use of the drug Translarna is criminal. This first use of a genetic therapy...

Read more

Saturday, 17 October 2015

Carmeseal-MD

An early access programme was announced for Carmeseal-MD™ (Poloxamer 188, NF) recently (http://www.phrixuspharmaceuticals.com/news.php) with the headline: "Phrixus Pharmaceuticals announces European Access Program for CarmesealMD™...

Read more

Thursday, 11 December 2014